Regeneron Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.02.14	BIOL Has Reason To Smile, CBMG Walks The Talk, CLSN Warms Up, REGN Catches Eyes (RTTNews)
24.02.14	Regeneron Says FDA Accepts For Review SBLA For EYLEA - Quick Facts (RTTNews)
11.02.14	Regeneron Pharma Reports Q4 Net Income Of 0.86 Per Share - Quick Facts (RTTNews)
10.02.14	Regeneron, Bayer Announce Results From Phase 3 VISTA Trial Of EYLEA (RTTNews)
14.01.14	Bayer und Regeneron entwickeln Therapie gegen Makula-Degeneration (Dow Jones)
14.01.14	Regeneron, Bayer To Co-develop Eylea Combination Therapy (RTTNews)
19.12.13	Sanofi, Regeneron To Collaborate With ACC For PCSK9 Inhibitor Clinical Program (RTTNews)
19.12.13	ALIM, PSDV Rally After Iluvien News, GILD Lays Out Plan, REGN Gets FDA Date (RTTNews)
18.12.13	Regeneron: FDA Accepts SBLA For EYLEA - Quick Facts (RTTNews)
22.11.13	Regeneron Says EYLEA Got Approval In Japan - Quick Facts (RTTNews)
22.11.13	Sanofi, Regeneron Report Positive Data With Sarilumab In Phase 3 Arthritis Trial (RTTNews)
22.11.13	Sanofi, Regeneron Report Positive Results With Sarilumab In First Phase 3 Trial (RTTNews)
07.11.13	Bayer HealthCare Submits MAA In European Union For EYLEA Injection (RTTNews)
05.11.13	Regeneron Pharma Q3 GAAP Profit Drops - Quick Facts (RTTNews)
21.10.13	Critical Alerts For Cisco, Chipotle Mexican Grill, Regeneron, SolarCity, and ARM Holdings Released By InvestorsObserver (PR Newswire)
21.10.13	Regeneron Pharma Reports Positive Topline Results For EYLEA Injection (RTTNews)
21.10.13	Regeneron Reports Positive Phase 3 Data for EYLEA® (aflibercept) Injection in Macular Edema Following Branch Retinal Vein Occlusion (PR Newswire)
16.10.13	Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar (PR Newswire)
16.10.13	Sanofi macht bei Entwicklung von neuem Cholesterinsenker Fortschritte (dpa-afx)
16.10.13	Sanofi, Regeneron Say Alirocumab Significantly Reduces Bad Cholesterol (RTTNews)
23.09.13	Conference Calls, New Appointments, Upcoming Presentations, Prospectus Filings and Acquisition Deal Updates - Research Report on Johnson & Johnson, WellPoint, Regeneron, Onyx, and MannKind (PR Newswire)
19.09.13	Critical Alerts For Cisco Systems, Petroleo Brasileiro S.A., General Motors (GM), Regeneron Pharmaceuticals, and Total S.A. Released By InvestorsObserver (PR Newswire)
18.09.13	Pipeline Developments, Product Recalls, Clinical Trial Results, Recognitions, and New Appointments - Research Report on Johnson & Johnson, Amgen, Regeneron, UnitedHealth, and Bristol-Myers (PR Newswire)
17.09.13	Regeneron to Present Phase 3 Data for EYLEA® (aflibercept) Injection in Diabetic Macular Edema at Upcoming Retina Society Meeting (PR Newswire)
14.09.13	Sanofi Likely To Repurchase 9% Stake Of L'Oreal (RTTNews)
10.09.13	Regeneron Names Robert Landry SVP, Finance & CFO - Quick Facts (RTTNews)
03.09.13	Pharmaceuticals Report Revolutionary Findings, Approved Treatments, Investor Conferences - Research Report on Celgene, Amgen, Biogen Idec, Regeneron, and Questcor (PR Newswire)
29.08.13	Regeneron:EC Oks Eylea Injection To Treat Visual Impairment Due To Macular Edema (RTTNews)
27.08.13	Regeneron Announces Upcoming 2013 Investor Conference Presentations (PR Newswire)
21.08.13	Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA (PR Newswire)
19.08.13	Critical Alerts For Microsoft, Amarin, Regeneron Pharmaceuticals, Best Buy, and Harley Davidson Released By InvestorsObserver (PR Newswire)
09.08.13	Quarterly Financial Results and Development Program Updates - Research Report on Regeneron, DaVita, Celldex, Isis, and VIVUS (PR Newswire)
07.08.13	Regeneron Granted Fundamental Patents Covering Mouse Antibody Technology Used in VelocImmune® Mice (PR Newswire)
06.08.13	Regeneron : Eye Drug Meets Primary Endpoint In Diabetic Macular Edema Trials (RTTNews)
06.08.13	Regeneron Reports Second Quarter 2013 Financial and Operating Results (PR Newswire)
26.07.13	Regeneron Says CHMP Recommends For Approval Of Eylea Injection - Quick Facts (RTTNews)
24.09.12	MÄRKTE EUROPA/Schwache Konjunktursignale belasten (Dow Jones)
24.09.12	Bayer: Aflibercept für EU zur Zulassung bei feuchter altersbedingter Makula-Degeneration empfohlen (Aktiencheck)
08.03.12	Bayer: EYLEA in Australien zur Behandlung der feuchten altersbedingten Makula-Degeneration zugelassen (Aktiencheck)
20.02.12	Bayer: Ergebnisse von Phase-III-Studie mit VEGF Trap-Eye bei Zentralvenenverschluss der Netzhaut positiv (Aktiencheck)
28.11.11	UPDATE: Bayer will Augenmittel auch in China vermarkten (Dow Jones)
28.11.11	Bayer führt Phase III-Studie für VEGF Trap-Eye in China durch (Dow Jones)
04.08.09	Regeneron Reports Second Quarter 2009 Financial and Operating Results (Businesswire)
30.04.09	Regeneron Reports First Quarter 2009 Financial and Operating Results (Businesswire)
31.07.08	Regeneron Reports Second Quarter 2008 Financial and Operating Results (Businesswire)
27.02.08	FDA Approves Regeneron's ARCALYST(TM) (rilonacept) for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) (Businesswire)
03.08.07	Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD) (Businesswire)
01.08.07	Regeneron Reports Second Quarter Financial and Operating Results (Businesswire)
03.05.05	Clinical and Pre-Clinical Studies of the VEGF Trap Show Potential for (Businesswire)
28.03.05	Regeneron Announces Presentation at the Lehman Brothers Eighth Annual (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

24.12.24		Börse New York: NASDAQ 100-Anleger greifen am Dienstagmittag zu
24.12.24		Dienstagshandel in New York: NASDAQ 100 startet in der Gewinnzone
19.12.24		Optimismus in New York: NASDAQ 100 startet im Plus
17.12.24		Schwacher Wochentag in New York: NASDAQ 100 verbucht letztendlich Abschläge
17.12.24		Minuszeichen in New York: NASDAQ 100 verliert nachmittags
17.12.24		Zurückhaltung in New York: NASDAQ 100 präsentiert sich schwächer
12.12.24		Schwache Performance in New York: NASDAQ 100 zeigt sich schlussendlich schwächer
12.12.24		Angespannte Stimmung in New York: NASDAQ 100 präsentiert sich schwächer

24.12.24

Börse New York: NASDAQ 100-Anleger greifen am Dienstagmittag zu

24.12.24

Dienstagshandel in New York: NASDAQ 100 startet in der Gewinnzone

19.12.24

Optimismus in New York: NASDAQ 100 startet im Plus

17.12.24

Schwacher Wochentag in New York: NASDAQ 100 verbucht letztendlich Abschläge

17.12.24

Minuszeichen in New York: NASDAQ 100 verliert nachmittags

17.12.24

Zurückhaltung in New York: NASDAQ 100 präsentiert sich schwächer

12.12.24

Schwache Performance in New York: NASDAQ 100 zeigt sich schlussendlich schwächer

12.12.24

Angespannte Stimmung in New York: NASDAQ 100 präsentiert sich schwächer

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Regeneron Pharmaceuticals Inc.

Aktien Top/Flop

Regeneron Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten